#BEGIN_DRUGCARD DB04109

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H14BN2O3

# Chemical_IUPAC_Name:
[amino({4-[(1,3,2-dioxaborolan-2-yloxy)methyl]phenyl})methylidene]azanium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine

# HET_ID:
SBZ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H13BN2O3/c12-10(13)9-3-1-8(2-4-9)7-16-11-14-5-6-15-11/h1-4H,5-7H2,(H3,12,13)/p+1

# InChI_Key:
InChIKey=XCLFQXCQQHVLJQ-UHFFFAOYSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4109

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
221.041

# Molecular_Weight_Mono:
221.10974779

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1S85

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.5

# Predicted_LogS:
-2.8

# Predicted_Water_Solubility:
4.00e-01 g/l

# Primary_Accession_No:
DB04109

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5289339

# PubChem_Substance_ID:
46505423

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02862

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC(=[NH2+])C1=CC=C(COB2OCCO2)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:58 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
PRSS3

# Drug_Target_1_GenBank_ID_Gene:
X72781

# Drug_Target_1_GenBank_ID_Protein:
6066378

# Drug_Target_1_GeneCard_ID:
PRSS3

# Drug_Target_1_Gene_Name:
PRSS3

# Drug_Target_1_Gene_Sequence:
>787 bp
GGGCCTGGAGCTGCACCCGCTTCTGGGTGGACGCACTTGGCGAGCGGCGCGGGATGCAGA
CGGCTGCGAGGCGCTGGGCACAGTTGCTGTCCCCTTTGACGATGATGACAAGATTGTTGG
GGGCTACACCTGTGAGGAGAATTCTCTCCCCTACCAGGTGTCCCTGAATTCTGGCTCCCA
CTTCTGCGGTGGCTCCCTCATCAGCGAACAGTGGGTGGTATCAGCAGCTCACTGCTACAA
GACCCGCATCCAGGTGAGACTGGGAGAGCACAACATCAAAGTCCTGGAGGGGAATGAGCA
GTTCATCAATGCGGCCAAGATCATCCGCCACCCTAAATACAACAGGGACACTCTGGACAA
TGACATCATGCTGATCAAACTCTCCTCACCTGCCGTCATCAATGCCCGCGTGTCCACCAT
CTCTCTGCCCACCGCCCCTCCAGCTGCTGGCACTGAGTGCCTCATCTCCGGCTGGGGCAA
CACTCTGAGCTTTGGTGCTGACTACCCAGACGAGCTGAAGTGCCTGGATGCTCCGGTGCT
GACCCAGGCTGAGTGTAAAGCCTCCTACCCTGGAAAGATTACCAACAGCATGTTCTGTGT
GGGCTTCCTTGAGGGAGGCAAGGATTCCTGCCAGCGTGACTCTGGTGGCCCTGTGGTCTG
CAACGGACAGCTCCAAGGAGTTGTCTCCTGGGGCCATGGCTGTGCCTGGAAGAACAGGCC
TGGAGTCTACACCAAGGTCTACAACTATGTGGACTGGATTAAGGACACCATCGCTGCCAA
CAGCTAA

# Drug_Target_1_General_Function:
Involved in protease activity

# Drug_Target_1_General_References:
11827488	Katona G, Berglund GI, Hajdu J, Graf L, Szilagyi L: Crystal structure reveals basis for the inhibitor resistance of human brain trypsin. J Mol Biol. 2002 Feb 1;315(5):1209-18.
2326201	Tani T, Kawashima I, Mita K, Takiguchi Y: Nucleotide sequence of the human pancreatic trypsinogen III cDNA. Nucleic Acids Res. 1990 Mar 25;18(6):1631.
8294000	Wiegand U, Corbach S, Minn A, Kang J, Muller-Hill B: Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. Gene. 1993 Dec 22;136(1-2):167-75.

# Drug_Target_1_HGNC_ID:
HGNC:9486

# Drug_Target_1_HPRD_ID:
06685

# Drug_Target_1_ID:
2886

# Drug_Target_1_Locus:
9p11.2

# Drug_Target_1_Molecular_Weight:
32499

# Drug_Target_1_Name:
Trypsin-3

# Drug_Target_1_Number_of_Residues:
304

# Drug_Target_1_PDB_ID:
1H4W

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00089	Trypsin

# Drug_Target_1_Protein_Sequence:
>Trypsin-3 precursor
MCGPDDRCPARWPGPGRAVKCGKGLAAARPGRVERGGAQRGGAGLELHPLLGGRTWRAAR
DADGCEALGTVAVPFDDDDKIVGGYTCEENSLPYQVSLNSGSHFCGGSLISEQWVVSAAH
CYKTRIQVRLGEHNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARV
STISLPTAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSM
FCVGFLEGGKDSCQRDSGGPVVCNGQLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTI
AANS

# Drug_Target_1_Reaction:
Preferential cleavage: Arg!, Lys! INHIBITOR Tos-Lys-CH2Cl; Tos-Arg-CH2Cl

# Drug_Target_1_Signals:
Not Available

# Drug_Target_1_Specific_Function:
Preferential cleavage:Arg-|-Xaa, Lys-|-Xaa

# Drug_Target_1_SwissProt_ID:
P35030

# Drug_Target_1_SwissProt_Name:
TRY3_HUMAN

# Drug_Target_1_Synonyms:
Brain trypsinogen
EC 3.4.21.4
Mesotrypsinogen
Serine protease 3
Serine protease 4
Trypsin III
Trypsin IV
Trypsin-3 precursor

# Drug_Target_1_Theoretical_pI:
7.54

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04109
